Vladimir Bilim

2.6k total citations
81 papers, 2.1k citations indexed

About

Vladimir Bilim is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Vladimir Bilim has authored 81 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 24 papers in Pulmonary and Respiratory Medicine and 21 papers in Oncology. Recurrent topics in Vladimir Bilim's work include Renal and related cancers (13 papers), Wnt/β-catenin signaling in development and cancer (13 papers) and Prostate Cancer Treatment and Research (12 papers). Vladimir Bilim is often cited by papers focused on Renal and related cancers (13 papers), Wnt/β-catenin signaling in development and cancer (13 papers) and Prostate Cancer Treatment and Research (12 papers). Vladimir Bilim collaborates with scholars based in Japan, United States and Sweden. Vladimir Bilim's co-authors include Yoshihiko Tomita, Andrei V. Ougolkov, Noboru Hara, Kota Takahashi, Daniel D. Billadeau, Takashi Kasahara, Takashi Kawasaki, Kaori Yuuki, Teiichi Motoyama and Sei Naito and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

Vladimir Bilim

78 papers receiving 2.0k citations

Peers

Vladimir Bilim
Josef Brueggen Switzerland
Antoun Toubaji United States
Sebastian Oltean United Kingdom
Ergin Kilic Germany
Shi‐Ming Tu United States
Ricardo Costa United States
Josef Brueggen Switzerland
Vladimir Bilim
Citations per year, relative to Vladimir Bilim Vladimir Bilim (= 1×) peers Josef Brueggen

Countries citing papers authored by Vladimir Bilim

Since Specialization
Citations

This map shows the geographic impact of Vladimir Bilim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vladimir Bilim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vladimir Bilim more than expected).

Fields of papers citing papers by Vladimir Bilim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vladimir Bilim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vladimir Bilim. The network helps show where Vladimir Bilim may publish in the future.

Co-authorship network of co-authors of Vladimir Bilim

This figure shows the co-authorship network connecting the top 25 collaborators of Vladimir Bilim. A scholar is included among the top collaborators of Vladimir Bilim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vladimir Bilim. Vladimir Bilim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murata, Masaki, et al.. (2023). MicroRNAs as Potential Regulators of GSK-3β in Renal Cell Carcinoma. Current Issues in Molecular Biology. 45(9). 7432–7448. 2 indexed citations
2.
Bilim, Vladimir, et al.. (2023). Targeting Pro-Survival Autophagy Enhanced GSK-3β Inhibition-Induced Apoptosis and Retarded Proliferation in Bladder Cancer Cells. Current Oncology. 30(6). 5350–5365. 3 indexed citations
3.
Bilim, Vladimir, et al.. (2023). Megalourethra and bladder foreign body in a female patient. SHILAP Revista de lepidopterología. 11(6). e7528–e7528. 2 indexed citations
4.
Bilim, Vladimir, et al.. (2022). Incidental detection of localized prostate cancer with low PSA by computed tomography scan: A report of two cases. SHILAP Revista de lepidopterología. 10(12). e6736–e6736. 3 indexed citations
5.
Bilim, Vladimir, et al.. (2022). Tumor-infiltrating immune cell status predicts successful response to immune checkpoint inhibitors in renal cell carcinoma. Scientific Reports. 12(1). 20386–20386. 5 indexed citations
6.
Naito, Sei, Vladimir Bilim, Kaori Yuuki, et al.. (2010). Glycogen Synthase Kinase-3β: A Prognostic Marker and a Potential Therapeutic Target in Human Bladder Cancer. Clinical Cancer Research. 16(21). 5124–5132. 72 indexed citations
7.
Nakano, Yuko, et al.. (2008). Molecular targeting of Bcl-2 overcomes prostate cancer cell adaptation to XIAP gene downregulation. Prostate Cancer and Prostatic Diseases. 12(1). 34–40. 4 indexed citations
8.
Ougolkov, Andrei V., et al.. (2006). Associations among β-TrCP, an E3 ubiquitin ligase receptor, β-catenin, and NF-κB in colorectal cancer. 2003(2003). 103. 6 indexed citations
9.
Suzuki, Kazuya, Kenji Obara, Kazutoshi Yamana, et al.. (2006). Role of connective tissue growth factor in fibronectin synthesis in cultured human prostate stromal cells. Urology. 67(3). 647–653. 11 indexed citations
10.
Hara, Noboru, Hiroshi Koike, Vladimir Bilim, & Kota Takahashi. (2005). Placement of a urethral catheter into the ureter: An unexpected complication after retropubic suspension. International Journal of Urology. 12(2). 217–219. 19 indexed citations
12.
Tomita, Yoshihiko, Vladimir Bilim, Noboru Hara, Takashi Kasahara, & Kota Takahashi. (2003). Role of IRF‐1 and caspase‐7 in IFN‐γ enhancement of Fas‐mediated apoptosis in ACHN renal cell carcinoma cells. International Journal of Cancer. 104(4). 400–408. 45 indexed citations
13.
Ougolkov, Andrei V., Kaname Yamashita, Vladimir Bilim, et al.. (2003). Abnormal expression of E-cadherin, β-catenin, and c-erbB-2 in advanced gastric cancer: its association with liver metastasis. International Journal of Colorectal Disease. 18(2). 160–166. 32 indexed citations
14.
Saito, Toshihiro, Yoshihiko Tomita, Takashi Kawasaki, Vladimir Bilim, & Kota Takahashi. (2002). Subsequent Activation of Mitogen-Activated Protein Kinase after Adhesion of Transitional Cell Cancer Cells to Fibronectin. Urologia Internationalis. 69(2). 125–128. 5 indexed citations
15.
Suwa, Michihiro, Masayuki Takeda, Vladimir Bilim, & Kota Takahashi. (2000). Epidermoid cyst of the penis: A case report and review of the literature. International Journal of Urology. 7(11). 431–433. 26 indexed citations
16.
Bilim, Vladimir, Takashi Kasahara, Noboru Hara, Kota Takahashi, & Yoshihiko Tomita. (2000). Caspase involved synergistic cytotoxicity of bcl-2 antisense oligonucleotides and Adriamycin on transitional cell cancer cells. Cancer Letters. 155(2). 191–198. 27 indexed citations
17.
Bilim, Vladimir, Yoshihiko Tomita, Takashi Kawasaki, Masayuki Takeda, & Kota Takahashi. (1998). Variable Bcl-2 phenotype in benign and malignant lesions of urothelium. Cancer Letters. 128(1). 87–92. 15 indexed citations
18.
Bilim, Vladimir, Yoshihiko Tomita, Takashi Kawasaki, Masayuki Takeda, & Kazuhiro Takahashi. (1997). Adriamycin (ADM) induced apoptosis in Transitional Cell Cancer (TCC) cell lines accompanied by p21 WAF1/CIP1 induction. APOPTOSIS. 2(2). 207–213. 8 indexed citations
19.
Tomita, Yoshihiko, Takashi Kawasaki, Vladimir Bilim, Masayuki Takeda, & Kota Takahashi. (1996). Tetrapeptide DEVD-aldehyde or YVAD-chloromethylketone inhibits Fas/Apo-1 (CD95)-mediated apoptosis in renal-cell-cancer cells. International Journal of Cancer. 68(1). 132–135. 24 indexed citations
20.
Kawasaki, Takashi, et al.. (1996). Abrogation of apoptosis induced by DNA-damaging agents in human bladder-cancer cell lines withp21/WAF1/CIP1 and/orp53 gene alterations. International Journal of Cancer. 68(4). 501–505. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026